Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de United Laboratories International Holdings Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), United Laboratories International Holdings Ltd tiene un total de activos de $25,833, una ganancia neta profit de $2,659

Question 2

¿Cuáles son los ratios financieros clave para ULIHF?

Accepted Answer

El ratio corriente de United Laboratories International Holdings Ltd es 2.25, el margen neto es 19.32, las ventas por acción son $7.57.

Question 3

¿Cómo se desglosan los ingresos de United Laboratories International Holdings Ltd por segmento o geografía?

Accepted Answer

United Laboratories International Holdings Ltd largest revenue segment is Bulk Medicine, at a revenue of 6,909,415,147 in the most earnings release.For geography, China, including Hong Kong is the primary market for United Laboratories International Holdings Ltd, at a revenue of 12,051,782,799.

Question 4

¿Es rentable United Laboratories International Holdings Ltd?

Accepted Answer

yes, según los últimos estados financieros, United Laboratories International Holdings Ltd tiene una ganancia neta profit de $2,659

Question 5

¿Tiene United Laboratories International Holdings Ltd alguna deuda?

Accepted Answer

yes, United Laboratories International Holdings Ltd tiene una deuda de 11,444

Question 6

¿Cuántas acciones en circulación tiene United Laboratories International Holdings Ltd?

Accepted Answer

United Laboratories International Holdings Ltd tiene un total de acciones en circulación de 1,817.02

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	14,101	13,758	13,739	11,334	9,703	8,772
Revenue Growth (YoY)	1%	0%	21%	17%	11%	5%
Cost of Revenue	7,439	7,676	7,405	6,365	5,492	4,966
Gross Profit	6,661	6,082	6,334	4,968	4,211	3,806
Selling, General & Admin	2,375	2,341	2,381	2,354	2,628	2,291
Research & Development	942	890	757	593	465	339
Operating Expenses	3,107	3,042	3,053	2,862	3,051	2,555
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	3,806	3,288	3,344	2,006	1,202	882
Income Tax Expense	746	631	643	425	213	181
Net Income	3,062	2,659	2,701	1,581	988	702
Net Income Growth	5%	-2%	71%	60%	41%	10%
Shares Outstanding (Diluted)	1,816.93	1,816.81	1,817.02	1,819.73	1,840.04	1,765.96
Shares Change (YoY)	0%	0%	0%	-1%	4%	8%
EPS (Diluted)	1.68	1.46	1.48	0.86	0.53	0.39
EPS Growth	5%	-2%	71%	62%	35%	2%
Free Cash Flow	--	1,329	1,028	1,212	1,060	1,037
Free Cash Flow Per Share	--	0.73	0.56	0.66	0.57	0.58
Gross Margin	47.23%	44.2%	46.1%	43.83%	43.39%	43.38%
Operating Margin	25.2%	22.08%	23.88%	18.58%	11.94%	14.24%
Profit Margin	21.71%	19.32%	19.65%	13.94%	10.18%	8%
Free Cash Flow Margin	--	9.65%	7.48%	10.69%	10.92%	11.82%
EBITDA	--	3,654	3,846	2,658	1,779	1,864
EBITDA Margin	--	26.55%	27.99%	23.45%	18.33%	21.24%
D&A For EBITDA	--	615	565	552	620	614
EBIT	3,554	3,039	3,281	2,106	1,159	1,250
EBIT Margin	25.2%	22.08%	23.88%	18.58%	11.94%	14.24%
Effective Tax Rate	19.6%	19.19%	19.22%	21.18%	17.72%	20.52%

United Laboratories International Holdings Ltd (ULIHF) Price

ULIHF Stock Price Chart

ULIHF Income

Follow-Up Questions